Patient NAME : Mr.
SK HABIB Barcode NO : 13120104
Age/Gender : 52 Y/Male Registration ON : 04/Oct/2024
LabNo : 012410041131 Sample Collected ON : 04/Oct/2024
Referred BY :Dr. S SANTRA Sample Received ON : 04/Oct/2024
CLIENT CODE :WBCL/NAPP/BHT Report Generated ON : 04/Oct/2024
Refer Lab/Hosp : Sample STATUS : Final Approved
Lab Address :AS 130, Block-H, R M Road, Kol: 157 Other Info :
DEPARTMENT OF HEMATOLOGY
Test Name Value Unit Bio Ref.Interval
RE - Blood
Haemoglobin 14.3 g/dL 13-17
(Method:Spectrophotometry) (Sample:EDTA Whole Blood)
WBC Count,Total 9,800 cells/μl 4000-10000
(Method:Flow cytometry) (Sample:EDTA Whole Blood)
Differential Leucocyte Count
Neutrophils 78 % 40 - 70
(Method:Cell Impedance ) (Sample:EDTA Whole Blood)
Lymphocytes 17 % 20 - 40
(Method:Cell Impedance ) (Sample:EDTA Whole Blood)
Monocytes 02 % 02 - 10
(Method:Cell Impedance ) (Sample:EDTA Whole Blood)
Eosinophils 03 % 01 - 06
(Method:Cell Impedance ) (Sample:EDTA Whole Blood)
Basophils 00 % 00-02
(Method:Cell Impedance ) (Sample:EDTA Whole Blood)
ESR 9 mm in 1hr ≤12
(Method:Westergren method) (Sample:EDTA Whole Blood)
Myelocyte and Metamyelocyte 00 % -
(Method:microscopic) (Sample:EDTA Whole Blood)
Promyelocyte 0 % -
(Method:Microscopic) (Sample:EDTA Whole Blood)
Please clinically correlate. Partial reproduction of test reports is strictly prohibited.
The reports are strictly for the use of medical practitioners and are not medical diagnosis.
Comments:
Haemoglobin transports oxygen. It is the main component of RBCs and a good indicator of anaemia.
WBC count can be used to diagnose infection and inflammation, and to monitor response to chemotherapy or radiotherapy. White cell differential provides more specific information about the
immune system. There are five major types of WBC: ϠNeutrophils; ϠLymphocytes; ϠMonocytes; ϠEosinophils; ϊBasophils.
The ESR measures the degree of erythrocyte (RBC) settling in a specified period. The ESR is sensitive but nonspecific, and is commonly the earliest indicator of disease when other chemical or
physical signs are normal. Normal range depends on the technique used (e.g. Westergren, Wintrobe or Seditainer).
Platelet Count 365 10^9/L 150-410
(Method:Electrical Impedance ) (Sample:EDTA Whole Blood)
Malarial Parasite (Thick & Thin) Not Found -
(Method:Leishman Giemsa Stain - Light Microscopy)
(Sample:EDTA Whole Blood)
Page 1 of 4
Patient NAME : Mr.SK HABIB Barcode NO : 13120104
Age/Gender : 52 Y/Male Registration ON : 04/Oct/2024
LabNo : 012410041131 Sample Collected ON : 04/Oct/2024
Referred BY :Dr. S SANTRA Sample Received ON : 04/Oct/2024
CLIENT CODE :WBCL/NAPP/BHT Report Generated ON : 04/Oct/2024
Refer Lab/Hosp : Sample STATUS : Final Approved
Lab Address :AS 130, Block-H, R M Road, Kol: 157 Other Info :
DEPARTMENT OF HEMATOLOGY
Test Name Value Unit Bio Ref.Interval
Please clinically correlate. Partial reproduction of test reports is strictly prohibited.
The reports are strictly for the use of medical practitioners and are not medical diagnosis.
Note: A single negative result does not rule out Malaria.
Comments:
Malaria is an acute febrile illness with an incubation period of 7 days or longer. Thus, a febrile illness developing less than 1 week after the first possible exposure is
not malaria.The most severe form is caused by P. falciparum; variable clinical features include fever, chills, headache, muscular aching and weakness, vomiting,
cough, diarrhoea and abdominal pain. Other symptoms related to organ failure may supervene, such as acute renal failure, pulmonary oedema, generalized
convulsions, circulatory collapse, followed by coma and death.The initial symptoms, which may be mild, may not be easy to recognize as being due to malaria.It is
important that the possibility of falciparum malaria is considered in all cases of unexplained fever starting at any time between 7 days after the first possible exposure
to malaria and 3 months (or, rarely, later) after the last possible exposure. Any individual who experiences a fever in this interval should immediately seek diagnosis
and effective treatment, and inform medical personnel of the possible exposure to malaria infection. Falciparum malaria may be fatal if treatment is delayed
beyond 24 h after the onset of clinical symptoms.
Page 2 of 4
Patient NAME : Mr.SK HABIB Barcode NO : 13120104
Age/Gender : 52 Y/Male Registration ON : 04/Oct/2024
LabNo : 012410041131 Sample Collected ON : 04/Oct/2024
Referred BY :Dr. S SANTRA Sample Received ON : 04/Oct/2024
CLIENT CODE :WBCL/NAPP/BHT Report Generated ON : 04/Oct/2024
Refer Lab/Hosp : Sample STATUS : Final Approved
Lab Address :AS 130, Block-H, R M Road, Kol: 157 Other Info :
DEPARTMENT OF BIOCHEMISTRY
Test Name Value Unit Bio Ref.Interval
Bilirubin Total 0.91 mg/dL Adults- 0.3-1.2
(Method:DPD) (Sample:Serum) Children (0-1 Day) 1.4-8.7
Children (1-2 Day) 3.4-11.5
Children (3-5 Day) 1.5-12.0
Bilirubin Direct 0.18 mg/dL <0.2
(Method:DPD) (Sample:Serum)
Bilirubin Indirect 0.73 mg/dl 0.2-0.8
(Method:Calculated) (Sample:Serum)
Please clinically correlate. Partial reproduction of test reports is strictly prohibited.
The reports are strictly for the use of medical practitioners and are not medical diagnosis.
Comments:
1. Bilirubin is a waste product derived from the heme moeity of the heamoglobin released from senescent or damaged erythrocytes.
2. Total bilirubin is the sum of the unconjugated and conjugated fractions.
3. Total bilirubin is elevated in conditions causing obstration of the bill duct, hepatitis(jaundice), cirrohosis, in haemolytic disorders and ceveral inherited enzyme deficiencies. Indirect bilirubin
is elevated by prehepatic causes such as haemolyitc disorders or liver diseases resulting in inpaired entry, tranport or conjugation within the liver.
4. Monitoring of bilirubin in the new born, particularly if pre mature is off particular importance. Unconjugated bilirubin if not bound to albumin is able to cross the blood drain barrier more
easily, increasing the denger of cereval damage.
Page 3 of 4
Patient NAME : Mr.SK HABIB Barcode NO : 13120104
Age/Gender : 52 Y/Male Registration ON : 04/Oct/2024
LabNo : 012410041131 Sample Collected ON : 04/Oct/2024
Referred BY :Dr. S SANTRA Sample Received ON : 04/Oct/2024
CLIENT CODE :WBCL/NAPP/BHT Report Generated ON : 04/Oct/2024 09:19PM
Refer Lab/Hosp : Sample STATUS : Final Approved
Lab Address :AS 130, Block-H, R M Road, Kol: 157 Other Info :
DEPARTMENT OF IMMUNOLOGY
WIDAL (SLIDE AGLUTINATION TEST)
1:20 1:40 1:80 1:160 1:320
S. typhi (O) + + - - -
S. typhi (H) + + - - -
S. paratyphi A (H) - - - - -
S. paratyphi B (H) - - - - -
Ref. Index: '+' = Agglutination is seen, '-' = No Agglutination is seen.
Comments:
Sera from normal adult individual may sometimes agglutinate these antigens in moderate dilutions.
A titre of 1:80 or more for 'O' agglutinin and a titre in excess of 1:160 for 'H' agglutinin is considered significant.
A rise in titre between two sera specimens is more meaningful than a single test. If the first sample is taken late in the disease, a rise in titre may not be demonstrable. Instead, there
may be a fall in titre. Patients already treated with antibiotics may not show any rise in titre, instead there may be fall in titre.
Antibodies to 'H' and 'O' antigens begin to arise during end of first week. The test may be negative in early part of first week.
Patients who have received vaccines against Salmonella and patients showing anamnestic response may give false positive reactions. True untreated infection results in rise in titre
where as vaccinated individuals and anamnestic cases do not demonstrate any rise in titre on repeating the test after a week.
It's recommended that results of the test should be corelated with the clinical findings to arrive at the final diagonosis.
Please clinically correlate. Partial reproduction of test reports is strictly prohibited.
The reports are strictly for the use of medical practitioners and are not medical diagnosis.
Sample: O.S.S
*** End Of Report ***
Page 4 of 4
